By InvitationNot Applicable

Registry of MIUS for Urolithiasis (ReMIUS-U)

Turkey (Türkiye)10,000 participantsStarted 2023-05-10

Plain-language summary

The purpose of this registry is to collect data on patients who have undergone minimally invasive treatments for urinary system stone disease, including percutaneous nephrolithotomy (PCNL), shock wave lithotripsy (SWL), semi-rigid ureterorenoscopy (URS), and flexible ureterorenoscopy (F-URS).

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * To have a medical indication for urolithiasis * Complete data of treatment and follow-up course * Patients with consent * Patients \> 18 years-old * Patients \< 18 years-old Exclusion Criteria: * Missing data * Patients without consent * Not to have a medical indication for urolithiasis treatment * To have a contraindication for urolithiasis treatment

What they're measuring

Operative durations of each treatment technique (PCNL, SWL, URS, F-URS)

Timeframe: Operation/procedure day

Operative radiation dosage of each treatment technique (PCNL, SWL, URS, F-URS)

Timeframe: Operation/procedure day

Operative results of each treatment technique (PCNL, SWL, URS, F-URS)

Timeframe: Operation/procedure day

Postoperative results

Timeframe: immediately after procedure

Rate of postoperative complication

Timeframe: up to 3 months, postoperatively

Follow-up

Timeframe: up to 10 years

Trial details

NCT IDNCT06394908

SponsorMarmara University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2030-05

View on ClinicalTrials.gov More Urolithiasis trials